Clinical Trial Update: A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) [Phase 4]

View source ↗

Summary

Pilot Phase 4 trial evaluating mirabegron plus pelvic floor exercise for overactive bladder symptoms in Parkinson's disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Parkinson Disease

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Daniel Burdick, MD | Conditions: Parkinsons Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-08-16